Electronica Shanghai Successfully Concludes: Nanochap Shows New Heights in Biomedical Chip Technology

The  Electronica Shanghai  was successfully concluded last month. The exhibition gathered leading companies and innovative technologies from the global electronics industry, among which biomedical chips, as an important display area, attracted the attention of many professional visitors. Among the many exhibiting companies, Nanochap Electronic Technology Co., Ltd. has become the focus of attention in the industry with its excellent biomedical chip technology.

Nanochap exhibited a variety of biomedical chip products at the show, covering the entire process from biomolecular signal detection to vital signs detection to neurostimulation intervention. The formation of this closed-loop technology not only reflects Nanochap's comprehensive layout and profound strength in the biomedical field, but also lays a solid foundation for the company's future development.

Biomolecular Signal Detection

In the field of biomolecule signal detection, Nanochap has demonstrated excellent performance with its BMS003 biomolecule signal processing chip, which is able to accurately capture and analyze tiny biomolecule signals (glucose, lactic acid, uric acid, ketone bodies, cholesterol, creatinine, etc.) in body fluids, such as sweat, saliva, urine, tissue fluids, etc. The first generation of the BMS series was launched and put into use in 2021, and has already been iterated. The first generation of the BMS series was launched in 2021 and put into use, and now it has been iterated to the third generation, the BMS003 chip has not only entered the mass production stage successfully, but also is the concentrated manifestation of Nanochap's technical strength.

The BMS003 chip incorporates advanced low-power technology and high-precision measurements in its design, realizing ultra-low power consumption while ensuring high-precision data acquisition. This excellent performance enables the BMS003 chip to maintain a high degree of reliability and stability even in complex and changing application environments.

It is worth mentioning that, in the field of continuous glucose monitoring (CGM), Nanochap, as a leading company in China, has shown its unique advantages with its BMS003 chip. This chip is the first one in China to adopt both 1.5V and 3V power supply versions, an innovative design that ensures stable performance while significantly reducing the overall power consumption of the system.

This not only enables the CGM device to achieve continuous monitoring over a long period of time, reducing the inconvenience caused by frequent battery replacement or charging, but also improves the patient's experience, providing diabetic patients with a more convenient and efficient way to manage their blood glucose.

Vital Signs Detection

Nanochap's technology is capable of accurately detecting a wide range of bioelectrical signals, providing reliable technical support for non-invasive testing and athletes' fitness testing.

In this exhibition, Nanochap especially demonstrated its new series of modules for vital signs detection (ECG, EEG, EMG, etc.). Based on Nanochap's Vital Signs Parameter Detection Chip EPC001, this series of modules integrates a variety of sensor technologies, which are capable of real-time monitoring of various vital signs parameters of the human body, such as heart rate, blood pressure, blood oxygen, pulse rate, relaxation, concentration, etc. The modules can be processed and analyzed by high-precision algorithms and data analysis. Through high-precision algorithm processing and data analysis, this series of modules can provide accurate and reliable physiological data, providing powerful support for health management and disease prevention.

Neurostimulation Intervention

Nanochap's leading programmable universal stimulation chip ENS001 and multi-functional stimulation chip NS4 not only bring revolutionary breakthroughs in the treatment of neurological diseases, but also provide unprecedented possibilities for neurological rehabilitation. These high-precision and highly flexible chip technologies can precisely regulate neural signals and help patients to recover and rebuild neural functions, thus bringing them a better and more efficient treatment and rehabilitation experience.

Through the exhibition and communication at Electronica Shanghai, Nanochap not only demonstrated its leading technical strength and innovation in the field of biomedical chips, but also established closer ties with many partners. In the future, Nanochap will continue to dedicate to the R&D and application promotion of biomedical chip technology, and provide more advanced and reliable biomedical chip products and solutions for our customers. Meanwhile, we also look forward to working with more partners to jointly promote the development and progress of the biomedical chip industry.